The Peptide Research Wiki
for Science-Based Information

Evidence-based profiles for BPC-157, semaglutide, GHK-Cu, and 74 more research compounds — with PubMed citations, mechanism breakdowns, and a free reconstitution calculator.

All data is provided for laboratory research purposes only. Not for human or animal consumption. All referenced compounds are research reagents.

82
Compounds Indexed
11
Research Categories
82+
PubMed References
Free
Reconstitution Calculator

Browse Peptides by Research Area

Most-Researched Compounds

Browse by What You're Studying

Find the right compounds faster. Each goal links directly to the relevant category in the compound library.

Compound Comparisons

Structured mechanism comparisons for the most-searched compound pairs — receptor pharmacology, pharmacokinetics, and published study data.

All comparisons →

Latest from the research blog

Plain-English summaries of recent peptide research, with primary citations.

Abstract network of interconnected molecular nodes representing seven peptides studied in immune function research.
Research Overview13 min read

Best Peptides for Immune Function Research: 7 Compounds Ranked by Evidence

Ranking 7 peptides studied for immune function research by mechanism and evidence depth, from RCT-backed Thymosin Alpha-1 to early-stage Selank and KPV.

Jul 12, 2026
Abstract hexagonal molecule motif representing kisspeptin-10 and gonadorelin research in HPG axis signaling.
Compound Comparison10 min read

Kisspeptin-10 vs Gonadorelin: Comparing Two Approaches to HPG Axis Research

Kisspeptin-10 activates GnRH neurons upstream while gonadorelin binds pituitary receptors directly: compare mechanism, evidence, and FDA approval history.

Jul 11, 2026
Abstract hexagonal molecule motif representing two long-acting GHRH research peptides, tesamorelin and CJC-1295 with DAC.
Compound Comparison9 min read

Tesamorelin vs CJC-1295 with DAC: Long-Acting GHRH Analogues Compared

Tesamorelin's ~30-minute half-life vs CJC-1295 with DAC's 6-8 day albumin-bound persistence: see how these two GHRH analogues compare in mechanism and FDA status.

Jul 10, 2026
Abstract calendar and gavel motif representing the FDA Pharmacy Compounding Advisory Committee hearing on peptide 503A status.
Regulatory & Policy8 min read

FDA PCAC July 2026: What to Expect at the July 23–24 Peptide Compounding Hearing

FDA's Pharmacy Compounding Advisory Committee meets July 23–24, 2026 to review 7 peptides for 503A status. Here's the schedule, docket number, and how to watch.

Jul 9, 2026
Abstract neural network motif representing Selank peptide research and its ClinicalTrials.gov registry status.
Research Overview7 min read

Selank ClinicalTrials.gov Registry: Trial Status and Research Access

ClinicalTrials.gov lists zero trials for Selank despite its 2009 Russian drug registration — see the 2008 62-patient study behind it and what the gap means for research access.

Jul 7, 2026
Abstract mitochondrial network motif representing MOTS-c peptide research in a Phase 2a insulin sensitivity clinical trial.
Regulatory & Policy7 min read

NCT07505745 Phase 2a Trial: MOTS-c Insulin Sensitivity Research Data

NCT07505745 is a Phase 2a trial testing MOTS-c in 120 prediabetic adults, targeting insulin sensitivity via the Matsuda Index over 12 weeks. See the full design.

Jul 6, 2026

Volumetric Reconstitution Calculator

Enter your vial parameters — the syringe updates live. U-100 and tuberculin configurations.

Quick load:
5 mg
2 mL
250 mcg
Draw
10.0units
0.100 mL  ·  2500 mcg/mL
Config
U-100 Insulin
Open Full Calculator
Syringe Visualization — Live
02040608010010uU-100 (1.0mL)
Vial: 5mgBAC: 2mLDose: 250mcg